Thin basement membrane nephropathy and renal transplantation.

Area of Science:

• Nephrology
• Transplantation Immunology
• Genetics

Background:

• Thin basement membrane nephropathy (TBMN) is a condition affecting the glomerular basement membrane.
• While often benign, TBMN can progress to end-stage renal failure (ESRF), necessitating renal transplantation.
• TBMN must be differentiated from Alport syndrome due to distinct clinical and genetic implications.

Purpose of the Study:

• To explore the clinical implications of TBMN in renal transplantation for both recipients and donors.
• To highlight the importance of distinguishing TBMN from Alport syndrome.
• To discuss the controversies and unknowns regarding live kidney donation from individuals with TBMN.

Main Methods:

• Review of clinical implications of TBMN in renal transplantation.
• Discussion of differential diagnosis between TBMN and Alport syndrome.
• Analysis of risks and uncertainties associated with live donor nephrectomy in TBMN patients.

Main Results:

• ESRF in TBMN patients may stem from co-existing glomerular or interstitial lesions, some of which can recur post-transplant (e.g., IgA disease).
• Failure to distinguish TBMN from Alport syndrome can lead to missed genetic counseling opportunities and risk of post-transplant anti-GBM disease.
• The risks of live kidney donation for individuals with TBMN or carriers of X-linked Alport syndrome are largely unknown.

Conclusions:

• TBMN presents unique challenges in renal transplantation, affecting both graft survival and donor safety.
• Accurate diagnosis and understanding of TBMN pathophysiology are essential for patient management and risk stratification.
• Further research into the clinical, pathological, and molecular aspects of TBMN is needed to optimize donor selection and patient outcomes.